Poliovirus vaccine live - sanofi-pasteur

Drug Profile

Poliovirus vaccine live - sanofi-pasteur

Alternative Names: IMOVAX Polio; Inactivated Polio Vaccine - Sanofi; IPV - Sanofi; OPV - Sanofi; OPV-Merieux; Opvero; Oral Polio Vaccine - Sanofi; Vaccin Antipoliomyelitique/Merieux; Vacina Poliomielitica

Latest Information Update: 29 May 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator sanofi pasteur
  • Developer Sanofi Pasteur
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Poliomyelitis

Most Recent Events

  • 04 May 2012 No development reported - Phase-II for Poliomyelitis in Philippines (IM)
  • 04 May 2012 No development reported - Phase-II for Poliomyelitis in Philippines (Intradermal)
  • 03 May 2012 Launched for prevention of Poliomyelitis in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top